The Chinese Academy of Sciences can’t be any worse. Much better than Sichuan University in the same city.
Last year, the Polymer Chemistry and Physics Department of the Chengdu Institute of Organic Chemistry was not fully occupied, and one quota was needed. It shouldn’t be difficult to apply for the exam. Compared with popular chemistry institutes such as the Institute of Chemistry of the Chinese Academy of Sciences, Dalian Institute of Chemical Physics, Changchun Institute of Applied Chemistry and Shanghai Institute of Organic Chemistry, the exam is much easier.
In accordance with the overall strategy and layout adjustment of the Knowledge Innovation Project of the Chinese Academy of Sciences, Chengdu Organic Chemistry Co., Ltd. of the Chinese Academy of Sciences was registered in June 2001 through the overall restructuring of the Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, which was founded in 1958. was established as a high-tech enterprise in the field of pharmaceutical chemicals and materials that attaches equal importance to high-tech innovation and industrial development.
The company currently has more than 400 employees. Among them, there are more than 130 scientific and technical personnel with doctorate and master's degrees, 32 researchers, 24 doctoral supervisors, more than 40 experts enjoying special government allowances from the State Council, 2 talents from the national "New Century Hundreds and Thousands of Talents Project", and national outstanding natural science experts. There are 2 Youth Fund winners, 5 talents from the “Hundred Talents Program” of the Chinese Academy of Sciences, 12 talents from the “Light of the West” from the Chinese Academy of Sciences, 10 academic and technological leaders from Sichuan Province, and 8 outstanding experts with outstanding contributions from Sichuan Province.
The company is a "National High-tech Research and Development Plan Achievements Industrialization Base" recognized by the Ministry of Science and Technology. It owns the National Engineering Research Center for Chiral Drugs (in preparation) and the Sichuan Provincial Key Experiment for Asymmetric Synthesis and Chiral Technology. It has strong scientific and technological innovation capabilities and has undertaken a number of national research projects, the "863" plan, and the "973" Plan, Natural Science Foundation, national, provincial and ministerial industrialization projects, and enterprise entrusted cooperation projects, have achieved a number of core technological achievements with independent intellectual property rights, applied for nearly 300 invention patents, and obtained more than 100 domestic and international authorized invention patents. , and won more than 100 national, provincial and ministerial level scientific and technological achievement awards. The company's high-tech industry has begun to take shape, and currently has 7 holding high-tech enterprises. Its products include chiral pharmaceutical intermediates and fine chemicals, catalysts, oilfield chemicals, urban and industrial sewage treatment chemicals, leather chemical materials, and lithium-ion batteries. materials and functional polymer materials, etc.
The company is also an important training base for senior talents in the chemistry discipline in my country. It has 5 master's degree programs in organic chemistry, physical chemistry, analytical chemistry, applied chemistry, polymer chemistry and physics, and 2 master's programs in organic chemistry and applied chemistry. There are 1 doctoral program, 1 chemistry postdoctoral research station, and more than 170 graduate students and postdoctoral fellows.
The "JOURNAL OF NATURAL GAS CHEMISTRY" edited and published by the company is publicly distributed at home and abroad. "Synthetic Chemistry" is a core domestic journal and has been selected into the CA Thousand List.
The company is people-oriented, adheres to the development strategy of "enhancement and expansion", is committed to knowledge innovation and high-tech industrial development, and strives to build the company into a company with pharmaceutical intermediates, fine chemicals and new materials as its main development directions. It is a high-tech enterprise group company integrating technology, industry and trade with sustainable development capabilities.